Gliclazide
A sulfonylurea antihyperglycemic agent.
General information
Gliclazide is a drug used for treatment of hyperglycaemia in non-insulin-dependent diabetes mellitus. It acts via insulin release stimulation in β cells in pancreas (DrugBank).
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
Envelope protein Small molecule In vitro |
In vitro ion channel assay | 2.99 | Blocks the SARS-CoV-2 E protein ion channel in vitro. |
Jun/20/2020 |